| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | 14.162 | 86.331 | 133.975 | 123.603 | 214.072 | 342.566 |
| Total Income - EUR | - | - | - | - | 14.162 | 86.331 | 133.975 | 123.603 | 214.790 | 342.515 |
| Total Expenses - EUR | - | - | - | - | 12.192 | 75.202 | 115.896 | 116.196 | 198.496 | 297.410 |
| Gross Profit/Loss - EUR | - | - | - | - | 1.970 | 11.128 | 18.080 | 7.407 | 16.293 | 45.105 |
| Net Profit/Loss - EUR | - | - | - | - | 1.542 | 10.066 | 16.763 | 6.355 | 14.446 | 38.971 |
| Employees | - | - | - | - | 1 | 1 | 2 | 2 | 3 | 3 |
Check the financial reports for the company - Biotech Group Distribution S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | 0 | 3.170 | 2.283 | 1.977 | 10.535 | 7.342 |
| Current Assets | - | - | - | - | 7.204 | 21.526 | 42.410 | 44.421 | 81.332 | 97.908 |
| Inventories | - | - | - | - | 3.447 | 8.692 | 20.382 | 29.399 | 34.303 | 54.028 |
| Receivables | - | - | - | - | 1.925 | 9.190 | 10.974 | 9.939 | 28.731 | 21.177 |
| Cash | - | - | - | - | 1.832 | 3.643 | 11.053 | 5.083 | 18.298 | 22.702 |
| Shareholders Funds | - | - | - | - | 1.584 | 11.620 | 28.125 | 34.512 | 48.854 | 87.552 |
| Social Capital | - | - | - | - | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | 5.620 | 13.076 | 16.567 | 11.886 | 43.013 | 17.699 |
| Income in Advance | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4690 - 4690" | |||||||||
| CAEN Financial Year |
4690
|
|||||||||
Comments - Biotech Group Distribution S.r.l.